Solidarity Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-3,526
Closed -$244K 91
2023
Q1
$244K Buy
+3,526
New +$249K 0.11% 83
2022
Q3
$2.68M Buy
33,831
+8,104
+31% +$588K 1.55% 18
2022
Q2
$1.9M Buy
25,727
+7,412
+40% +$565K 1.02% 27
2022
Q1
$1.4M Buy
+18,315
New +$1.23M 0.78% 28

Other funds holding BMY

Solidarity Wealth's BMY Position: Q2 2023 in Review

Solidarity Wealth sold out of Bristol-Myers Squibb (BMY) in Q2 2023, closing a stake of 3,526 shares — an estimated $244K sold.

Solidarity Wealth first reported a position in BMY in Q1 2022 and held it in 4 quarters. The position peaked at $2.68M in Q3 2022. 2,480 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

  • Solidarity Wealth reported no remaining Bristol-Myers Squibb position as of Q2 2023 after selling out during the quarter.
  • Solidarity Wealth sold 3,526 Bristol-Myers Squibb shares in Q2 2023, an estimated $244K.
  • Solidarity Wealth first reported a position in Bristol-Myers Squibb in Q1 2022 and held it in 4 quarters.
  • Solidarity Wealth's Bristol-Myers Squibb position peaked at $2.68M in Q3 2022.
  • 2,480 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on Solidarity Wealth's 13F filing for Q2 2023, filed 10 Aug 2023.